Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,672 | -30,074 | -17,854 | -15,485 | -43,688 |
| Depreciation Amortization | 5,569 | 4,047 | 2,567 | 1,209 | 2,582 |
| Accounts receivable | 658 | -4,837 | -2,214 | 388 | -296 |
| Other Working Capital | -3,338 | -17,788 | -11,817 | -6,069 | -13,251 |
| Other Operating Activity | 13,478 | 15,736 | 9,000 | 3,524 | 15,602 |
| Operating Cash Flow | $-28,305 | $-32,916 | $-20,318 | $-16,433 | $-39,051 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 72,496 | 41,772 | 44,001 | 31,255 | -22,198 |
| PPE Investments | -2,172 | -2,020 | -1,590 | -797 | -5,151 |
| Other Investing Activity | 32 | 32 | 32 | -1 | -8 |
| Investing Cash Flow | $70,356 | $39,784 | $42,443 | $30,457 | $-27,357 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,453 | 5,145 | 2,872 | 1,538 | 68,015 |
| Common Stock Repurchased | -2,741 | -2,741 | N/A | N/A | -19 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -3,112 |
| Financing Cash Flow | $3,712 | $2,404 | $2,872 | $1,538 | $64,884 |
| Beginning Cash Position | 10,423 | 10,423 | 10,423 | 10,423 | 11,947 |
| End Cash Position | 56,186 | 19,695 | 35,420 | 25,985 | 10,423 |
| Net Cash Flow | $45,763 | $9,272 | $24,997 | $15,562 | $-1,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,305 | -32,916 | -20,318 | -16,433 | -39,051 |
| Capital Expenditure | -2,172 | -2,020 | -1,590 | -797 | -5,151 |
| Free Cash Flow | -30,477 | -34,936 | -21,908 | -17,230 | -44,202 |